Published in Chest on September 01, 2011
Statins and delirium during critical illness: a multicenter, prospective cohort study. Crit Care Med (2014) 1.60
Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial. Lancet Respir Med (2016) 1.55
Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria. PLoS Pathog (2012) 1.11
Associations of markers of inflammation and coagulation with delirium during critical illness. Intensive Care Med (2012) 1.02
Statin use and risk of delirium in the critically ill. Am J Respir Crit Care Med (2014) 0.96
The evolving landscape of neurotoxicity by unconjugated bilirubin: role of glial cells and inflammation. Front Pharmacol (2012) 0.96
Pharmacological and nonpharmacological management of delirium in critically ill patients. Neurotherapeutics (2012) 0.94
Future directions of delirium research and management. Best Pract Res Clin Anaesthesiol (2012) 0.79
Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future development. J Pain Symptom Manage (2014) 0.78
Association between statin use at admission to inpatient rehabilitation and functional status at discharge among older patients. Rejuvenation Res (2014) 0.75
Missing link or not, mobilise against delirium. Crit Care (2014) 0.75
Intensive Care Unit Delirium: A Review of Diagnosis, Prevention, and Treatment. Anesthesiology (2016) 0.75
Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature (2000) 11.49
Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA (2004) 11.27
Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA (2001) 10.63
The inflammatory reflex. Nature (2002) 9.10
Microglia in neurodegenerative disease. Nat Rev Neurol (2010) 5.83
Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med (2009) 4.69
Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med (2010) 4.69
Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med (2001) 3.87
The safety of statins in clinical practice. Lancet (2007) 3.85
Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation (2002) 3.48
Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci (2005) 3.33
Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients. Crit Care Med (2010) 3.32
Displacement of synaptic terminals from regenerating motoneurons by microglial cells. Z Zellforsch Mikrosk Anat (1968) 2.91
Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis (2007) 2.84
The association between delirium and cognitive decline: a review of the empirical literature. Neuropsychol Rev (2004) 2.72
Statins for the prevention of dementia. Cochrane Database Syst Rev (2009) 2.38
Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J (1996) 2.37
Systemic infection and delirium: when cytokines and acetylcholine collide. Lancet (2010) 2.36
The impact of systemic infection on the progression of neurodegenerative disease. Nat Rev Neurosci (2003) 2.35
Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology (2007) 2.17
Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem (2004) 1.99
Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience (2002) 1.90
Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain (2008) 1.77
Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury. J Neurotrauma (2007) 1.76
Sepsis-associated delirium. Intensive Care Med (2007) 1.72
Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J Neurosci (1998) 1.68
The neuroinflammatory hypothesis of delirium. Acta Neuropathol (2010) 1.49
Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis, and neuronal survival in rats subjected to traumatic brain injury. J Neurotrauma (2004) 1.49
Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism. J Neuroinflammation (2008) 1.46
C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation (1997) 1.45
Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation (2000) 1.41
Delirium and long-term cognitive impairment. Int Rev Psychiatry (2009) 1.38
Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures. J Neuroinflammation (2005) 1.36
Effect of rosuvastatin on amnesia and disorientation after traumatic brain injury (NCT003229758). J Neurotrauma (2008) 1.29
Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury. Exp Neurol (2007) 1.26
Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis (2006) 1.26
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors attenuate beta-amyloid-induced microglial inflammatory responses. J Neurosci (2005) 1.25
Atorvastatin reduction of intravascular thrombosis, increase in cerebral microvascular patency and integrity, and enhancement of spatial learning in rats subjected to traumatic brain injury. J Neurosurg (2004) 1.22
Simvastatin attenuates microglial cells and astrocyte activation and decreases interleukin-1beta level after traumatic brain injury. Neurosurgery (2009) 1.16
Withdrawal of statin treatment abrogates stroke protection in mice. Stroke (2003) 1.13
Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice. Circ Res (2002) 1.12
Preoperative use of statins is associated with reduced early delirium rates after cardiac surgery. Anesthesiology (2009) 1.08
Delirium after elective surgery among elderly patients taking statins. CMAJ (2008) 1.07
HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages. J Biomed Sci (2003) 0.99
Beneficial microvascular and anti-inflammatory effects of pravastatin during sepsis involve nitric oxide synthase III. Br J Anaesth (2010) 0.96
Withdrawal of statins and risk of subarachnoid hemorrhage. Stroke (2009) 0.92
Lovastatin modulation of microglial activation via suppression of functional CD40 expression. J Neurosci Res (2004) 0.89
Statins in traumatic brain injury. Neurotherapeutics (2010) 0.89
Effects of statins on microglia. J Neurosci Res (2005) 0.85
Rebound inflammatory response during the acute phase of myocardial infarction after simvastatin withdrawal. Atherosclerosis (2009) 0.85
Lovastatin and mevastatin reduce basal and cytokine-stimulated production of prostaglandins from rat microglial cells in vitro: evidence for a mechanism unrelated to the inhibition of hydroxy-methyl-glutaryl CoA reductase. Neurosci Lett (2004) 0.82
Rosuvastatin reduces microglia in the brain of wild type and ApoE knockout mice on a high cholesterol diet; implications for prevention of stroke and AD. Biochem Biophys Res Commun (2010) 0.77
Withdrawal of cerivastatin induces monocyte chemoattractant protein 1 and tissue factor expression in cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (2003) 0.77